1. Home
  2. A vs KVUE Comparison

A vs KVUE Comparison

Compare A & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • A
  • KVUE
  • Stock Information
  • Founded
  • A 1999
  • KVUE 2022
  • Country
  • A United States
  • KVUE United States
  • Employees
  • A N/A
  • KVUE N/A
  • Industry
  • A Biotechnology: Laboratory Analytical Instruments
  • KVUE Specialty Chemicals
  • Sector
  • A Industrials
  • KVUE Consumer Discretionary
  • Exchange
  • A Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • A 38.6B
  • KVUE 43.6B
  • IPO Year
  • A 1999
  • KVUE 2023
  • Fundamental
  • Price
  • A $116.70
  • KVUE $23.69
  • Analyst Decision
  • A Buy
  • KVUE Buy
  • Analyst Count
  • A 13
  • KVUE 14
  • Target Price
  • A $151.50
  • KVUE $24.00
  • AVG Volume (30 Days)
  • A 2.1M
  • KVUE 15.0M
  • Earning Date
  • A 02-26-2025
  • KVUE 05-06-2025
  • Dividend Yield
  • A 0.85%
  • KVUE 3.46%
  • EPS Growth
  • A 4.31
  • KVUE N/A
  • EPS
  • A 4.36
  • KVUE 0.54
  • Revenue
  • A $6,533,000,000.00
  • KVUE $15,455,000,000.00
  • Revenue This Year
  • A $5.84
  • KVUE $1.55
  • Revenue Next Year
  • A $6.23
  • KVUE $4.12
  • P/E Ratio
  • A $26.77
  • KVUE $44.06
  • Revenue Growth
  • A N/A
  • KVUE 0.07
  • 52 Week Low
  • A $116.36
  • KVUE $17.67
  • 52 Week High
  • A $155.35
  • KVUE $24.46
  • Technical
  • Relative Strength Index (RSI)
  • A 29.80
  • KVUE 59.76
  • Support Level
  • A $117.92
  • KVUE $22.80
  • Resistance Level
  • A $124.43
  • KVUE $23.59
  • Average True Range (ATR)
  • A 2.97
  • KVUE 0.50
  • MACD
  • A 0.26
  • KVUE -0.04
  • Stochastic Oscillator
  • A 4.15
  • KVUE 67.94

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: